CONTROLLED SUBSTANCES LAWS AND REGULATIONS - PowerPoint PPT Presentation

About This Presentation
Title:

CONTROLLED SUBSTANCES LAWS AND REGULATIONS

Description:

Title: PowerPoint Presentation Last modified by: Wayne M Brown Created Date: 1/1/1601 12:00:00 AM Document presentation format: On-screen Show Other titles – PowerPoint PPT presentation

Number of Views:258
Avg rating:3.0/5.0
Slides: 80
Provided by: bWebUmkcE
Learn more at: http://b.web.umkc.edu
Category:

less

Transcript and Presenter's Notes

Title: CONTROLLED SUBSTANCES LAWS AND REGULATIONS


1
CONTROLLED SUBSTANCES LAWS AND REGULATIONS
  • Presented by
  • Susan McCann, R.Ph.
  • Administrator, BNDD

2
Topics to be Discussed
  • Controlled Substance Law
  • Drug Abuse / Impairment
  • Drug Diversion
  • Department of Health and Senior Services The
    Role of the BNDD
  • Laws and Regulations
  • Registration

3
Topics to be Discussed (continued)
  • Prescription Writing and Dispensing
  • Individual Practitioners Who can prescribe?
  • Long Term Care Facilities
  • Home Health / Hospice
  • Hospital practice orders versus prescriptions
  • Records
  • Security

4
Prescription Drug Abuse
  • Culture of drug use in our society
  • 5-6 of population abuses substances
  • 1st time users of prescription drugs for non-
    medical use
  • 1980s 0.5 million per year
  • 1998 1.6 million
  • 2000 gt2 million

5
National Household Survey on Drug Abuse
  • Conducted by Substance Abuse and Mental Health
    Services Administration (SAMHSA)
  • 15.9 million people were current illicit drug
    users representing 7.1 of the population 12
    years or older (up from 6.3 in 2000 and 4 in
    1999)
  • This figure rose to 19.5 million people in 2002
    (8.3) and 2003 (8.2).

6
Drug Abuse/Impairment
  • 10-17 of health care professionals will abuse
    drugs/alcohol during career
  • Physical/mental stresses
  • Recreational use
  • Knowledgeable about drugs/immune from harm
  • 65-85 of professional discipline is related to
    controlled substance/alcohol issues

7
Drug Abuse/Impairment (continued)
  • Consequences
  • Harm to patients
  • Harm to self
  • Harm to family
  • Harm to career
  • Professional discipline
  • Arrest and criminal prosecution

8
Drug Diversion
  • Occurs from all levels of controlled distribution
  • Manufacturers
  • Distributors
  • Pharmacies
  • Hospitals
  • Ambulances
  • Physician offices, etc.

9
Drug Diversion (continued)
  • Persons responsible
  • Pharmacists
  • Physicians
  • Nurses
  • Pharmacy technicians
  • Family members
  • Office staff
  • Custodians
  • Patients, etc.

10
Drug Diversion (continued)
  • Methods of diversion
  • Theft
  • Opportunistic
  • Planned access
  • Break-ins
  • Robberies

11
Drug Diversion (continued)
  • Methods of diversion (continued)
  • Record falsification
  • Forged, altered prescription
  • Administration records
  • Distribution records
  • Inventory records
  • Receiving records
  • Physician orders, etc.

12
Department of Health and Senior Services BNDD
  • Organization/staffing
  • Registrations
  • Inspections/investigations
  • Administrative actions
  • Education

13
Laws and Regulations
  • State and federal controlled substances acts
  • Closed system of registration, record keeping and
    security
  • Similarities/differences
  • Not all subjects covered by both

14
Laws and Regulations (cont.)
  • Other state agency controlled substance laws and
    regulations
  • Boards of professional licensure
  • Pharmacy, Healing Arts, Dentistry, Podiatry,
    Optometry, Veterinary Medicine
  • Department of Health and Senior Services
  • Health Facilities Regulation Unit-Hospitals
  • Section for Long Term Care - LTCF
  • Home Health/Hospice Unit
  • Emergency Medical Services Unit Ambulance
    services

15
References for Laws and Regulations
  • DHSS www.dhss.mo.gov/BNDD
  • Board of Pharmacy
  • http//pr.mo.gov/regulated-professions.asp
  • Drug Enforcement Administration
  • www.deadiversion.usdoj.gov

16
Schedules of Controlled Substances
  • CI CV based upon potential for abuse
  • CI no accepted medical use
  • Research is allowed
  • Analytical laboratories
  • Dog handlers (law enforcement)

17
Schedules of Controlled Substances
  • Criteria
  • Potential for abuse
  • Pharmacological effect
  • Current scientific knowledge of substance
  • History of abuse
  • Scope, duration and significance of abuse
  • Risk to public health
  • Potential for psychic or physical dependence
  • Whether an immediate precursor of a current
    controlled substance

18
Schedules of Controlled Substances (continued)
  • Differences state and federal
  • Codeine cough syrups CIV in Missouri
  • Ephedrine CIV in Missouri
  • Missouri will schedule a substance after DEA does
    unless there is an objection

19
Schedules of Controlled Substances (continued)
  • Non-controlled abusable agents
  • Carisoprodol
  • Nalbuphine
  • Tramadol
  • Advertising not allowed for any schedule

20
Registration
  • Requirements
  • All legitimate controlled substance activities
  • Agents excepted pharmacist, nurse, employees
    are not registered
  • No registration issued if controlled substance
    conviction
  • Misdemeanor 2 years
  • Felony 7 years

21
Registration (continued)
  • Process
  • Application, renewal notice
  • Notify BNDD of change of name, address, or
    ownership
  • Expiration 3 years

22
Registration - Discipline
  • Administrative
  • Warning
  • Censure
  • Probation
  • Suspension
  • Revocation
  • Denial

23
Registration - Discipline
  • Criminal
  • Federal civil fines, imprisonment
  • Refusal to make or keep records is a misdemeanor
  • Theft, false prescriptions, and false records are
    felonies.

24
Records
  • General
  • Authority to review by DHSS, Board of Pharmacy,
    law enforcement
  • Readily retrievable
  • Separate, or
  • Electronic or mechanical access, or
  • Visually identifiable
  • Provide within three (3) working days
  • Keep two (2) years (Rxs five (5) years)
  • Keep on site, except as allowed

25
Records (continued)
  • Required information
  • Drug name
  • Form
  • Strength
  • Quantity per container
  • Number of containers
  • Date of transaction
  • Name/address of person dispensed to
  • Name/initial of person dispensing
  • Any other type of disposition
  • Goal records are reconcilable

26
Records (continued)
  • Purchasing records
  • Invoices
  • Record of date received
  • BNDD audit problems
  • Permission for central records
  • DEA Official Order Forms
  • Record quantity and date received
  • Only person with POA may sign form to order

27
Records (continued)
  • Inventory records
  • Annual/biennial
  • Opening/close of business day specified
  • Exact count CII or if gt 1,000 per container
  • Board of Pharmacy requires at PIC change
  • Continuous or perpetual
  • No requirement except hospital/LTCF (must be
    reconciled periodically)
  • Dispensing records
  • Will be covered under Prescription Writing and
    Dispensing

28
Records (continued)
  • Transfer records
  • To other pharmacies, physicians, ambulances, etc.
  • Use Official Order Form (OOF) for CII
  • No borrow loan without record, OOF
  • Distributor registration if gt 5 total dosage
    units
  • Office use by practitioner cannot obtain with
    prescription

29
Records (continued)
  • Returns to supplier unusable, expired
  • Disposal records
  • DEA authorized destroy on site, DEA form
  • Reverse distributor
  • Hospital pharmacy or patient care areas
  • Loss reports

30
Security
  • Physical security
  • Effective controls based on schedules and
    quantities stocked
  • CII
  • Substantially constructed, securely locked
    cabinet
  • Limited access
  • LTCF double lock, unless unit dose

31
Security (continued)
  • Physical security (continued)
  • CIII-V
  • Allowed to be dispersed in pharmacy
  • Locked in all other settings
  • Dispensing area security
  • Employees
  • Family
  • Friends

32
Security (continued)
  • Waivers to employ required
  • For a person with any conviction regarding
    controlled substances, if that person will have
    any access to controlled substances
  • For previous revocation/surrender of a controlled
    substance registration

33
Security (continued)
  • Diversion
  • Theft or record keeping
  • Illegal possession possession except as
    authorized by Chapter 195 RSMo
  • Felony
  • DEA Diversion Task Force arresting patients and
    licensed professionals

34
Security (continued)
  • Reporting losses
  • Police
  • BNDD
  • Any theft/significant loss
  • Report upon discovery
  • Loss report form within 7 days
  • Permission for interim report
  • Summary, name of thief, police report
  • Insignificant loss file with inventory

35
Security (continued)
  • Reporting losses (continued)
  • DEA
  • Call immediately
  • Form to follow
  • Board of Pharmacy
  • Notify with annual renewal (BNDD sends a copy of
    pharmacy loss reports to the Board monthly)

36
INTERMISSION
37
Prescribing
  • Purpose of prescription
  • Issued in good faith,
  • Issued in the course of professional practice,
    and
  • Issued for a legitimate medical reason

38
Prescribing (continued)
  • Authorized prescribers
  • Scope of practice
  • By profession as defined by licensing board /
    practice acts
  • No self prescribing (family is legal, but
    discouraged)
  • No de-tox/maintenance of narcotic addiction (as
    opposed to weaning)
  • Exception office-based treatment programs
    buprenorphine
  • Using hospital DEA
  • Temp license, resident, hospital employee
  • Only hospital patients no family, employees,
    friends
  • Military

39
Prescribing (continued)
  • Collaborative practice with nurses (MO)
  • RNs not LPNs or Pas
  • BHA/BON regulation
  • Agreement, scope of practice
  • May not prescribe controlled substances
  • Direct contact with physician before calling
    controlled substance Rx to pharmacy
  • BNDD regulation
  • May dispense/administer to patient after contact
    with physician
  • BNDD registration, no DEA

40
Prescription Writing and Dispensing
  • Rx can be filled only by RPh (not nurse or
    hospital)
  • Format, components for CS prescription
  • Dated on day signed
  • Name and address of patient
  • Drug name, strength, dosage form
  • Quantity (preferably written out)
  • Complete instructions (preferably not prn or
    as directed)
  • Specify refills

41
Prescription Writing and Dispensing
  • Format, components (continued)
  • Written signature
  • No stamp or computer generated signature
  • Name and address of prescriber
  • (and preferably telephone number)
  • DEA
  • Ink
  • Typewritten, computer generated original
  • Preprinted or photocopied confirm if
    questionable

42
Prescription Writing and Dispensing
  • Ensure Rx is legitimate and properly written
  • RPh has corresponding liability with prescriber
  • Changes or additions
  • Most are allowed after confirming with prescriber
  • Changes must be documented
  • Changes NOT allowed
  • Patient name
  • Drug name (except generic substitution)
  • Prescriber signature
  • Expiration no fill or refill after 6 months
    after date prescribed

43
Prescription Writing and Dispensing
  • CII Prescriptions
  • Always written, except special circumstances
  • NO refill
  • Oral (telephone) emergency
  • Immediate administration is necessary, no other
    drug is appropriate, cannot reasonable provide
    written prescription
  • Reduce to writing for filing
  • Quantity limited to emergency period
  • Confirm prescriber if unknown

44
Prescription Writing and Dispensing
  • CII Prescriptions
  • Emergency prescriptions (continued)
  • Written follow up prescription must be received
    within 7 days to provide authorization for
    emergency dispensing attach to oral Rx
  • Notify BNDD and DEA if no written Rx is received

45
Prescription Writing and Dispensing
  • CII Prescriptions -- FAX
  • Of original, signed prescription
  • Receive original prescription before dispensing
  • Emergency (same as oral emergency)
  • Original not required
  • LTCF
  • Hospice
  • Narcotic injection

46
Prescription Writing and Dispensing
  • CII Prescriptions FAX (continued)
  • Telephone number of originating FAX and date and
    time of transmission, must appear on FAX
  • File original FAX as prescription
  • Prescriber must maintain the original
    prescription on file.

47
Prescription Writing and Dispensing
  • CII Prescriptions (continued)
  • Computer
  • Must receive the original prescription before
    dispensing
  • Emergency (same as oral emergency)
  • Reduce to writing (printed form) for filing
  • Written prescription must be received within 7
    days

48
Prescription Writing and Dispensing
  • CII Prescriptions (continued)
  • Quantity
  • Thirty day supply prescribed or dispensed at one
    time
  • Oral/fax/computer emergency quantity for
    emergency period only
  • Medical reason documented
  • Up to a three month supply
  • Prescriber describes medical reason on Rx

49
Prescription Writing and Dispensing
  • CIII-CIV Prescriptions
  • Written
  • Oral reduce to writing for filing
  • FAX
  • Telephone number of FAX, date and time of
    transmission on FAX
  • File original FAX as prescription
  • Prescriber must maintain original prescription on
    file

50
Prescription Writing and Dispensing
  • CIII-CIV Prescriptions (continued)
  • Computer
  • Reduce to writing (printed form) for filing
  • Verify with prescriber within 30 days by
    telephone or by printout
  • Quantity 90 days supply
  • Refills
  • No more than 5 times within 6 months from Rx date
  • Monitor-- for early refills and total use
    compared to dose ordered

51
Prescription Writing and Dispensing
  • CV Prescriptions
  • Same as CIII-CIV
  • If prescribed, treat as prescription no refill
    unless authorized
  • OTC
  • RPh only
  • Purchaser must be at least 18 years of age
  • Purchaser not known to RPh must provide ID
  • Record in bound record book

52
Prescription Writing and Dispensing
  • Partial filling CII
  • Due to inadequate supply must fill remainder
    within 72 hours or notify prescriber
  • LTCF, terminally ill patient
  • Record on Rx LTCF or terminal illness
  • Record dates/quantities of fills
  • No fills after 60 days from Rx date
  • Partial filling CIII-IV up to total quantity
    within 6 months

53
Prescription Writing and Dispensing
  • DEA Proposed PKI process
  • Public key infrastructure (PKI) - Public and
    private IDs
  • Positive ID of sender
  • Guarantee confidentiality

54
Labeling of Prescriptions
  • Pharmacy name and address
  • Prescriber name
  • Patient name
  • Directions for use
  • Serial (prescription) number
  • Date of filling
  • CII-CIV -- Caution Criminal offense to
    transfer to person other than patient

55
Documentation on Prescriptions
  • Required
  • RPh signature and date
  • Quantity filled if different than prescribed
  • Recommended
  • Special instructions/communications
  • Name of person calling oral prescription

56
Prescription Records
  • Prescription Files
  • Three files required
  • CII
  • CIII-CV
  • Non- Controlled substance
  • Refill records
  • Manual record on back of Rx
  • Computerized records
  • All original Rx information
  • Refill history
  • Daily pharmacist verification printout or log

57
Prescription Records
  • Transferring Rx to another pharmacy
  • One time except if share on-line database
  • Record on hard copy except if shared database
  • Occurs between two RPhs
  • Documentation by transferor
  • Writes Void on face of Rx
  • Records pharmacy name, address, DEA and RPh
    receiver on reverse of Rx

58
Prescription Records
  • Transferring Rx to another pharmacy
  • Documentation by receiver of transfer
  • Transfer on face of Rx
  • Original date written
  • Original refills authorized
  • Original dispensing date
  • refills remaining
  • Dates of previous fills and locations
  • Pharmacy name, address, DEA and transferring RPh

59
Delivery by Common Carrier
  • Postal regulations
  • Prescription properly labeled
  • Plain wrapper
  • No controlled substance indicators on the
    outside
  • Loss report responsibility
  • Shipper is responsible

60
Prescription Monitoring Programs
  • Multiple copy manual systems
  • Electronic systems
  • 18-20 states
  • Federal law proposed in Congress 2002

61
Hospitals
  • Registration
  • As hospital, not as pharmacy
  • Administrator signs application as registrant
  • Licensing regulations
  • DHSS Bureau of Health Facility Regulation
  • Center for Medicare and Medicaid Services
  • Security
  • Locked storage
  • Authorized access

62
Hospitals
  • Records
  • CII routinely reconciled
  • CII-CV routinely reconciled outside pharmacy,
    reconcilable inside pharmacy
  • Prescribing/ordering
  • Written, oral, electronic signature acceptable
  • Distribution to patient care areas
  • Traditional floor stock
  • Automated floor stock
  • Discourage patient supply intermingled with other
    drugs

63
Hospitals
  • ER administering
  • Administer on oral order when prescriber not
    present
  • Nurse assess patient
  • Nurse confirm prescriber/patient relationship
  • Narcotic detox/treatment
  • If patient in hospital for other medical/surgical
    reasons

64
Long Term Care Facilities
  • Emergency Kit
  • Registration
  • LTCF registration, not pharmacy
  • No DEA number
  • Administrator signs application as registrant
  • Pharmacy supplier responsibility
  • Assure LTCF has policy and procedure in place to
    address security and record keeping

65
Long Term Care Facilities
  • Emergency kit (continued)
  • Initial stock and replacement stock
  • Transfer not patient prescription
  • Record keeping
  • Transfer record both pharmacy and LTCF
  • Accountability records
  • Administration records

66
Long Term Care Facilities
  • Patients own prescriptions
  • Written/oral/fax prescriptions usually from
    physicians office
  • Physicians order from LTCF to pharmacy
  • Nurse call/fax as prescription only if agent of
    physician
  • Pharmacist call physician or oral prescription
  • Control at facility
  • Security all locked, CII double locked unless
    unit dose
  • Records all CS reconciled

67
Home Health / Hospice
  • Patients residence
  • Security Access/who can administer
  • Records Staff must document CS delivery
  • Disposal Agency policy to discuss disposal with
    patient
  • Hospice facility
  • Registration E-kit or facility
  • Security
  • E-kit, stock, patient Rxs similar to LTCF /
    hospital
  • Special allowance for CS in patients room

68
Home Health / Hospice
  • Record keeping
  • Receiving E-kit, stock, patients own
    prescription
  • Reconcile CII each shift, CIII CV daily
  • Administration and waste similar to hospital

69
Individual Practitioners
  • Licensed by Division of Professional Registration
  • Physician
  • Dentist
  • Veterinarian
  • Podiatrist
  • Optometrist

70
Individual Practitioners
  • Registration
  • One registration allows all activities
  • Separate registration if has stock at gt1 site
  • Free-standing, non-licensed facilities
  • Individual practitioner must be registered at the
    location in order to stock CS
  • No facility registration
  • Physician or hospital owned clinics
  • Urgent care centers
  • Infusion centers
  • Dialysis centers

71
Individual Practitioners
  • Security
  • Locked storage
  • Limited access
  • Records
  • Prescribing
  • Administering
  • Dispensing
  • Receiving
  • Inventory
  • Other Disposition

72
Individual Practitioners
  • Prescribing
  • Record of all CS Rxs written, including refill
    authorizations
  • Rx may be communicated to pharmacy by agent a
    person employed or directly responsible to the
    prescriber
  • Dispensing
  • CS labeling requirements are similar to pharmacy
    labeling requirements

73
Individual Practitioners
  • Collaborative practice
  • RNs only no LPNs or Pas
  • May administer/dispense CS after direct consult
    with physician
  • May not prescribe CS, may call CS prescription in
    schedules III-V only at direction of physician

74
Listed Chemicals
  • Substances
  • Precursors to controlled substances
  • Ephedrine
  • Pseudoephedrine
  • Phenylpropanolamine
  • Essential chemicals (reagents, solvents)
  • Acetone Ethyl Ether
  • Iodine Potassium permanganate
  • Sulfuric acid Others

75
Listed Chemicals
  • Registration
  • BNDD -- not currently registering
  • DEA currently required for some activities
  • Reports DEA required based on threshold
    quantities

76
Listed Chemicals
  • Ephedrine single entity
  • No other active medicinal ingredient in
    therapeutic quantity
  • C IV in Missouri
  • DEA
  • Registration
  • Records of sales
  • Stored behind the counter

77
Listed Chemicals
  • Ephedrine combination, pseudoephedrine,
    phenylpropanolamine and combinations
  • Missouri Law any methamphetamine precursor drug
  • OTC sales
  • Maximum of 2 packages (6 total grams) of single
    entity pseudoephedrine or PPA.
  • Maximum of 3 packages (9 total grams) of
    combination product
  • Must keep single entity product behind the
    checkout counter or within 10 ft and an
    unobstructed view of an attended checkout
    counter.

78
Where to Get More Information
  • BNDD
  • Telephone (573)751-6321
  • FAX (573)526-2569
  • Board of Pharmacy
  • Telephone (573)751-0091
  • FAX (573)526-3464
  • TDD (800)735-2966
  • Drug Enforcement Administration
  • Telephone (913) 825-4100
  • FAX (913) 825-4182

79
QUESTIONS
Write a Comment
User Comments (0)
About PowerShow.com